These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 15361919)

  • 1. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor.
    Stahl SM; Pradko JF; Haight BR; Modell JG; Rockett CB; Learned-Coughlin S
    Prim Care Companion J Clin Psychiatry; 2004; 6(4):159-166. PubMed ID: 15361919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.
    Fava M; Rush AJ; Thase ME; Clayton A; Stahl SM; Pradko JF; Johnston JA
    Prim Care Companion J Clin Psychiatry; 2005; 7(3):106-13. PubMed ID: 16027765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and tolerability of bupropion in the treatment of major depressive disorder.
    Moreira R
    Clin Drug Investig; 2011 Oct; 31 Suppl 1():5-17. PubMed ID: 22015858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion: a review of its use in the management of major depressive disorder.
    Dhillon S; Yang LP; Curran MP
    Drugs; 2008; 68(5):653-89. PubMed ID: 18370448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.
    Labbate LA; Croft HA; Oleshansky MA
    J Clin Psychiatry; 2003; 64 Suppl 10():11-9. PubMed ID: 12971811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?
    Bijlsma EY; Chan JS; Olivier B; Veening JG; Millan MJ; Waldinger MD; Oosting RS
    Pharmacol Biochem Behav; 2014 Jun; 121():88-101. PubMed ID: 24128918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion: pharmacology and therapeutic applications.
    Foley KF; DeSanty KP; Kast RE
    Expert Rev Neurother; 2006 Sep; 6(9):1249-65. PubMed ID: 17009913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
    Stahl SM
    J Clin Psychiatry; 1998; 59 Suppl 4():5-14. PubMed ID: 9554316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant.
    Patel K; Allen S; Haque MN; Angelescu I; Baumeister D; Tracy DK
    Ther Adv Psychopharmacol; 2016 Apr; 6(2):99-144. PubMed ID: 27141292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation.
    Clark A; Tate B; Urban B; Schroeder R; Gennuso S; Ahmadzadeh S; McGregor D; Girma B; Shekoohi S; Kaye AD
    Health Psychol Res; 2023; 11():81043. PubMed ID: 37405312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.
    Thase ME; Haight BR; Richard N; Rockett CB; Mitton M; Modell JG; VanMeter S; Harriett AE; Wang Y
    J Clin Psychiatry; 2005 Aug; 66(8):974-81. PubMed ID: 16086611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues.
    Kim EJ; Felsovalyi K; Young LM; Shmelkov SV; Grunebaum MF; Cardozo T
    Psychopharmacology (Berl); 2018 Sep; 235(9):2643-2650. PubMed ID: 29961917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressants for smoking cessation.
    Hughes JR; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000031. PubMed ID: 17253443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
    Paterson NE; Balci F; Campbell U; Olivier BE; Hanania T
    J Psychopharmacol; 2011 Oct; 25(10):1357-64. PubMed ID: 20305042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion: Does Its Efficacy Outweigh Potential Morbidity and Lethality?
    Al-Namnakani B; Zell-Kanter M
    Pediatr Ann; 2023 May; 52(5):e178-e179. PubMed ID: 37159067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion as the treatment of choice in depression associated with Parkinson's disease and it's various treatments.
    Raskin S; Durst R
    Med Hypotheses; 2010 Dec; 75(6):544-6. PubMed ID: 20708340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
    Croft H; Settle E; Houser T; Batey SR; Donahue RM; Ascher JA
    Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.